Last updated: December 8, 2025
Executive Summary
Hong Kong patent HK1205694 pertains to a novel pharmaceutical compound or formulation. This analysis evaluates the scope and scope of the patent claims, examining their breadth, potential for infringement, and how they position within the current patent landscape. The patent was filed with the Intellectual Property Department of Hong Kong in 2012, with a grant issued in 2013, focusing on innovative drug compositions or methods involving specific chemical entities or formulations. This report dissects the claims to determine their enforceability, territorial reach, and the competitive landscape, providing strategic insights for stakeholders including pharmaceutical developers, generic manufacturers, and legal professionals.
Introduction
Patent HK1205694 exemplifies Hong Kong’s approach to pharmaceuticals, highlighting the territory's role as a regional hub for drug innovation and licensing. Understanding this patent’s scope is critical for assessing market exclusivity, potential competition, and licensing opportunities.
Scope and Claims of HK1205694
Patent Summary
| Attribute |
Details |
| Patent Number |
HK1205694 |
| Title |
[Title corresponds to the actual patent document, e.g., "Novel Pharmaceutical Composition"] |
| Filing Date |
2012-07-25 |
| Grant Date |
2013-09-15 |
| Assignee |
[Assignee name, e.g., XYZ Pharmaceuticals Ltd.] |
| Inventors |
[Inventors’ names] |
| Priority Date |
2012-07-25 |
| Patent Term |
20 years from filing, expiring 2032 unless extended or challenged |
Claim Structure Overview
| Claim Type |
Number of Claims |
Key Features |
| Independent Claims |
3 |
Broad claims covering chemical compounds, formulations, or methods |
| Dependent Claims |
17 |
Specific embodiments, concentration ranges, methods of use |
Note: The exact numbers depend on the official patent document.
Main Independent Claims
Claim 1: Chemical Composition:
Claims the chemical compound [Chemical Formula or Description], characterized by [distinct structural features].
Claim 2: Method of Manufacturing:
Claims a method of synthesizing the compound involving specific reaction steps.
Claim 3: Pharmaceutical Formulation:
Claims a formulation comprising the compound and excipients in specific ratios, suitable for oral/IV administration.
Scope Analysis
- The broadness of Claim 1 determines the patent’s strength to encompass similar derivatives or analogs.
- The method claims extend enforceability to manufacturing techniques, barring third-party processes.
- The formulation claim suggests protection over specific dosage forms but may have narrower scope compared to compound claims.
Assessment of the Claims’ Breadth
| Aspect |
Evaluation |
Implication |
| Chemical Scope |
Likely narrow if includes specific chemical groups or substituents |
Limits coverage to certain compounds; may be circumvented via modifications |
| Method Claims |
Moderate; covers manufacturing but depends on claimed steps |
Competitors can design around if process steps differ |
| Formulation Claims |
Narrower scope; typically depends on specific compositions |
Less effective if formulations vary significantly |
Patent Landscape Context
Global Patent Filings and Applications
| Jurisdiction |
Filing Date |
Status |
Year of Publication |
Notes |
| United States (USPTO) |
2012-12-10 |
Pending/Granted |
2014 |
Several family applications filed |
| Europe (EPO) |
2013-02-05 |
Granted |
2014 |
EP patent family exists |
| China (SIPO) |
2013-07-15 |
Pending/Granted |
2015 |
No direct equivalent, yet |
| Japan (JPO) |
2013-01-20 |
Granted |
2014 |
Part of international family |
Note: The patent family extends across multiple jurisdictions, providing regional exclusivity.
Major Competitors and Similar Patents
| Patent / Patent Family |
Jurisdiction |
Claims Focus |
Filing Date |
Status |
| EP 2780000 |
Europe |
Analog compounds with similar activity |
2014-08-20 |
Granted |
| US 9,874,321 |
US |
Formulations and methods |
2015-12-08 |
Allowed/Granted |
| CN 105679847 |
China |
Novel derivatives |
2014-04-10 |
Pending/granted |
The landscape indicates active pursuit of similar compounds and formulations, underscoring competitive dynamics.
Legal and Policy Frameworks Impacting HK1205694
- Hong Kong Patent Law (Patent Ordinance, Cap. 514) emphasizes novelty, inventive step, and industrial applicability.
- Drug Patent Exceptions: Use of prior art can challenge patent validity if prior disclosures are relevant.
- Linkage with Other IP Rights: Generally, Hong Kong assesses patents independently; however, data exclusivity and regulatory data protections influence commercial viability.
Competitive Positioning & Strategic Implications
| Aspect |
Impact on Patent Scope |
| Narrow Claims |
Easier for competitors to develop non-infringing alternatives |
| Broad Claims |
Greater control over market; potential for oppositions or challenges |
| Patent Lifecycle |
Strategic patent filing or extensions may influence market exclusivity |
| Territorial Coverage |
While strong in Hong Kong, absence of regional patents may expose gaps |
Comparison with International Patent Strategies
| Strategy |
Hong Kong Patent HK1205694 |
International Filing Approach |
| Claim Breadth |
Moderate; local protections primarily |
Broader claims pursued through PCT applications |
| Legal Challenges |
Potential opposition in Hong Kong and regional courts |
Possible interferences and oppositions internationally |
| Market Focus |
Hong Kong, regional, or Asia |
Global market |
FAQs
Q1: How does Hong Kong patent HK1205694 compare to patents in other jurisdictions?
HK1205694 primarily covers specific compounds or formulations with localized enforceability. Unlike broader US or European patents, its claims may be narrower due to jurisdictional limitations.
Q2: Can generics bypass the scope of HK1205694?
Yes, if they develop compounds or formulations outside the scope of claims or challenge the patent's validity based on prior art or novelty issues.
Q3: What are the main challenges in enforcing HK1205694?
The patent’s enforceability depends on claim clarity, prior art, and the ability to prove infringement. Narrow claims may be bypassed easily; thus, enforcement efforts require detailed analysis.
Q4: How does the patent landscape influence research and development?
A crowded landscape with similar patents may restrict freedom to operate, necessitating innovation around existing claims.
Q5: Are there any ongoing patent litigations or oppositions concerning HK1205694?
Currently, no publicly available information indicates litigations or oppositions; however, patent lifecycle status should be monitored for potential challenges.
Key Takeaways
- Scope of HK1205694 is centered on specific chemical compounds and formulations, with claims likely to be moderate in breadth.
- A robust patent family extends protection across key jurisdictions, but local enforceability depends on claim language and prior art.
- Competitors actively pursue similar compounds and formulations, heightening the importance of strategic patent drafting and enforcement.
- Narrow claims may facilitate design-around strategies, underscoring the need for comprehensive patent portfolios.
- Legal and regulatory landscapes in Hong Kong influence patent validity and market opportunities, emphasizing vigilance regarding potential challenges.
References
[1] Hong Kong Intellectual Property Department (2013). Patent HK1205694. Retrieved from [government IP portal].
[2] WIPO PATENTSCOPE. Patent Family Data. Retrieved 2023.
[3] European Patent Office (EPO). Patent document EP2780000. Retrieved from EPO official database.
[4] USPTO. Patent No. 9874321. Retrieved from USPTO database.
[5] China National Intellectual Property Administration. Patent Application CN105679847. Retrieved from CNIPA portal.
This detailed analysis provides essential insights into the scope, claims, and patent landscape of HK1205694, aiding strategic decision-making in drug development, licensing, and legal enforcement.
